Two Healthcare Stocks I'm Watching Now - 3-Minute Stock Analysis
Up Next
8 videosShould you buy Rivian stock? (February 2024)
February 23rd, 2024
Palantir Stock Analysis (January 2024)
January 15th, 2024
Should you buy Palantir stock? (August 2023)
August 23rd, 2023
Should you buy Rivian stock? (June 2023)
June 24th, 2023
This Small Cap Is Only 2x Earnings
October 20th, 2022
Should you buy Symbotic stock? (May 2024)
May 18th, 2024
Netflix earnings wasn't too hot #shorts
April 21st, 2023
This Growth Stock Just Collapsed! (Alarum Technologies)
August 29th, 2024
Published first at https://www.3minutebreakdowns.com Two healthcare stocks I'm watching now. Dutch biotech company Uniqure soared over 300% in September after releasing data that showed positive results for its treatment of Huntington’s disease. Uniqure’s experimental gene therapy is delivered directly into the brain and the company’s 3 year study showed a 75% slowing progression of the devastating disease. The news was greeted with euphoria and hailed as a stunning breakthrough by the scientific community. And the therapy could also be highly lucrative for Uniqure with gene therapy treatments often costing upwards of 2 millions dollars. However, on November 3rd, Uniqure stock gave back almost all its gains as it emerged the FDA would no longer accept the company’s data as robust enough to support a BLA submission. Investors scaled back their bets as a new study could take years to develop. ABOUT ME Joe is the original founder of 3-minute Breakdowns and editor for Overlooked Alpha, the number one newsletter for overlooked investing ideas and stock market analysis. Joe evaluates companies from a business-first perspective, searching for things that the market has got wrong and waiting for the 'fat pitch'. LINKS My website: https://www.3minutebreakdowns.com/ Koyfin charts: https://www.koyfin.com/affiliate/overlooked-alpha/?via=3mb TikTok: https://www.tiktok.com/@overlookedalpha X: https://x.com/OverlookedAlpha DISCLAIMER & DISCLOSURE This content is for educational and entertainment purposes only. 3-Minute Breakdowns is not a registered investment advisor and does not provide financial recommendations (only opinions). The information is being presented without consideration of the investment objectives, risk tolerance, or financial circumstances of any specific investor and might not be suitable for all investors. Past performance is not indicative of future results. All investing involves risk, including the possible loss of principal. The author reserves the right to buy and sell or change his position in a particular stock at any time. This description contains affiliate links that allow you to find the items that I personally use and recommend. Thank you for your support.

